T

The Center for Diabetes and Endocrine Care | Fort Lauderdale, FL

Research site

(Unclaimed)

Location

3107 Stirling Road, Suite 300, Fort Lauderdale, Florida, United States of America

Site insights

Top conditions

Top treatments

Levoketoconazole

BI 685509

Testosterone

Levothyroxine

clofutriben

Bococizumab

Empagliflozin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 14 total trials

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease (VitaliThy)

The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check...

Enrolling

Graves Disease

Graves' Disease

Biological: Efgartigimod PH20 SC

Other: Placebo PH20 SC

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism a...

Enrolling

Hypothyroidism

Drug: Levothyroxine

Drug: Armour Thyroid

Eversense® Non-adjunctive Use Post Approval Study (NA-PAS)

This is a non-blinded, prospective, multi-center, single arm longitudinal cohort study (patient serving as their own control), to evaluate the effect...

Active, not recruiting

Diabetes

Device: Blood glucose meter

Device: Eversense CGM System

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial...

Enrolling

Type 2 Diabetes

Cortisol Excess

Drug: clofutriben

Drug: Placebo